The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Diagnostics & Research
Guangzhou Wondfo Biotech Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.79% CNY27.67
America/New_York / 30 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 12 961 mill |
| EPS: | 1.130 |
| P/E: | 24.49 |
| Earnings Date: | May 16, 2024 |
| SharesOutstanding: | 468.41 mill |
| Avg Daily Volume: | 4.92 mill |
| RATING 2024-04-30 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.68x |
| Company: PE 24.49 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.85x |
| Company: PE 24.49 | industry: PE 28.70 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY13.67 (-50.59%) CNY-14.00 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 26.76 - 28.59 ( +/- 3.31%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY27.67 (3.79% ) |
| Volume | 9.57 mill |
| Avg. Vol. | 4.92 mill |
| % of Avg. Vol | 194.76 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 300482.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
300482.SZ
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.